1 January 2025 in Health Psychology
Psychological distress in cancer survivors may be partially attributable to fear of cancer recurrence (FCR). Simonelli et al. (2017) proposed a conceptual model of FCR, which suggests that cancer cues (e.g., physical symptoms) may prompt maladaptive emotional processing leading to heightened FCR, and thus increased psychological distress. This prospective study tested this model by examining the cascading pathways by which physical symptom burden, emotion dysregulation, and FCR were associated with posttraumatic stress symptoms (PTSS) and anxiety among recently diagnosed cancer survivors. Psychosocial and well-being data from 486 breast (63.7%), prostate (25.7%), and colorectal (10.7%) cancer survivors (Mage = 58.7 years; 31% male) were collected over 12 months as they transitioned off primary treatment into early survivorship. A path analysis was performed to examine whether physical symptom burden led to more emotion dysregulation and elevated FCR and, in turn, more psychological distress (PTSS and anxiety). Greater physical symptom burden at Time 1 was associated with more emotion dysregulation at Time 2, which was related to heightened FCR at Time 3 and, in turn, more psychological distress at Time 4. Additionally, the indirect effect of physical symptom burden on FCR through emotion dysregulation and the indirect effects of emotion dysregulation on PTSS and anxiety through FCR were also significant. The findings support Simonelli et al.'s (2017) conceptual model of FCR and distress and highlight the importance of assessing and addressing physical symptom burden and improving emotional processing abilities to help mitigate heightened psychological distress among cancer survivors. (PsycInfo Database Record (c) 2025 APA, all rights reserved).
13 November 2025 in medRxiv
Purpose: Female BRCA1/2 carriers face high breast cancer risks and complex preventive decisions, which can generate decisional conflict. Polygenic Risk Scores (PRS) offer individualized risk estimates that may support decision-making. We examine whether PRS disclosure reduces decisional conflict in BRCA1/2 carriers and whether PRS magnitude interacts with numeracy and tolerance for ambiguity. Methods: Unaffected BRCA1/2 carriers ( N= 354) were assessed pre PRS disclosure (T0), one-week (T1), and six-months post-disclosure (T2). PRS were translated into 10-year and lifetime absolute breast cancer risk estimates. Mixed-effects models tested changes in decisional conflict, and regression/moderation analyses tested PRS effects and interactions with numeracy and tolerance for ambiguity. Results: Decisional conflict decreased significantly after PRS disclosure. Higher 10-year risk was associated with greater decisional conflict immediately after disclosure. Lifetime risk alone did not predict conflict. Tolerance for ambiguity moderated the effect of lifetime risk at T1: women with low/average tolerance experienced higher conflict with high PRS and lower conflict with low PRS. Numeracy, age, and family cancer history did not moderate PRS effects. Conclusion: Decisional conflict decreased post-PRS disclosure, with short-term responses influenced by tolerance for ambiguity. Findings suggest that PRS can complement standard BRCA1/2 genetic counseling and highlight the need for tailored risk communication.
21 May 2026 in Genetics in Medicine
Women with BRCA1/2 pathogenic variants (PVs) face high breast cancer risks and complex preventive decisions, including whether to undergo risk-reducing mastectomy, which can generate decisional conflict. Polygenic Risk Scores (PRS) offer individualized risk estimates that may support informed preventive decisions. We examine whether PRS disclosure reduces decisional conflict about risk-reducing mastectomy in women with BRCA1/2 PVs and whether PRS magnitude interacts with individual characteristics. Unaffected women with BRCA1/2 PVs (N=354) were assessed pre PRS disclosure (T0), one-week (T1), and six-months post-disclosure (T2). PRS were translated into 10-year and lifetime absolute breast cancer risk estimates. Mixed-effects models tested changes in decisional conflict, and generalized regression analyses tested PRS effects and interactions with individual characteristics RESULTS: Decisional conflict decreased significantly after PRS disclosure. Higher 10-year risk was associated with greater decisional conflict immediately after disclosure. Lifetime risk alone did not predict conflict. Tolerance for ambiguity moderated the effect of lifetime risk at T1: women with lower or medium tolerance experienced higher conflict with high PRS and lower conflict with low PRS. Numeracy, age, and family cancer history did not moderate PRS effects. Decisional conflict decreased post-PRS disclosure, with short-term responses varying by tolerance for ambiguity, highlighting the importance of tailoring risk communication to patients' psychological characteristics.
7 October 2026 in Journal of Health Psychology
This longitudinal study was a secondary analysis of data from 569 cancer survivors ( M age = 59.2, SD = 11.48), diagnosed with breast, colorectal and prostate cancer. The associations between three dimensions of illness perceptions—perceived consequences, perceived control and perceived timeline, measured at baseline (T1), and symptoms of posttraumatic stress (PTSS) assessed at 6 months (T2) and 12 months (T3), were examined using multiple linear regressions. Higher perceived consequences at T1 were significantly associated with increases in PTSS at T2 and T3. Higher perceived control at T1 was also significantly associated with reductions in PTSS at T3 but not at T2. Perceived timeline at T1 was not associated with changes in PTSS at T2 or T3. The findings suggest that beliefs about consequences and control may play significant roles in both short- and long-term psychological adjustment among adult cancer survivors.